Fagan Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-28,328
| Closed | -$1.82M | – | 118 |
|
|
2018
Q4 | $1.82M | Sell |
28,328
-520
| -2% | -$33.3K | 0.93% | 36 |
|
|
2018
Q3 | $2.58M | Buy |
28,848
+2,785
| +11% | +$249K | 1.07% | 30 |
|
|
2018
Q2 | $2.07M | Sell |
26,063
-75
| -0.3% | -$5.96K | 0.93% | 35 |
|
|
2018
Q1 | $2.33K | Sell |
26,138
-4,342
| -14% | -$387 | 0.99% | 28 |
|
|
2017
Q4 | $3.18K | Buy |
30,480
+65
| +0.2% | +$7 | 1.29% | 23 |
|
|
2017
Q3 | $4.44M | Buy |
30,415
+1,383
| +5% | +$202K | 2.19% | 11 |
|
|
2017
Q2 | $3.77M | Buy |
29,032
+2,652
| +10% | +$344K | 1.96% | 13 |
|
|
2017
Q1 | $3.28M | Buy |
26,380
+1,250
| +5% | +$156K | 1.82% | 18 |
|
|
2016
Q4 | $2.91M | Sell |
25,130
-6,930
| -22% | -$802K | 1.68% | 18 |
|
|
2016
Q3 | $3.35M | Buy |
32,060
+550
| +2% | +$57.5K | 2.05% | 16 |
|
|
2016
Q2 | $3.11M | Buy |
31,510
+105
| +0.3% | +$10.4K | 2% | 17 |
|
|
2016
Q1 | $3.14M | Sell |
31,405
-16,635
| -35% | -$1.66M | 2.08% | 15 |
|
|
2015
Q4 | $5.75M | Buy |
48,040
+1,931
| +4% | +$231K | 3.82% | 3 |
|
|
2015
Q3 | $4.99M | Buy |
46,109
+1,490
| +3% | +$161K | 3.66% | 4 |
|
|
2015
Q2 | $5.16M | Buy |
44,619
+865
| +2% | +$100K | 3.45% | 4 |
|
|
2015
Q1 | $5.04M | Buy |
43,754
+2,355
| +6% | +$271K | 3.74% | 4 |
|
|
2014
Q4 | $4.63M | Buy |
41,399
+1,840
| +5% | +$206K | 3.68% | 4 |
|
|
2014
Q3 | $3.75M | Buy |
39,559
+1,105
| +3% | +$105K | 3.08% | 7 |
|
|
2014
Q2 | $3.3M | Buy |
38,454
+2,280
| +6% | +$196K | 2.82% | 8 |
|
|
2014
Q1 | $2.53M | Buy |
+36,174
| New | +$2.53M | 2.19% | 13 |
|